Neurological complications of hematopoietic stem cell transplantation

Cancer Neurology In Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition

Volumn , Issue , 2008, Pages 327-352

  Quant, Eudocia ^a   Wen, Patrick Y ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

bone marrow; graft versus host disease; hematopoietic; infection; stem cell transplantation

Indexed keywords

EID: 84891430047     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-412-4_18     Document Type: Chapter

References (161)

1. Goldman JM, Horowitz MM. The international bone marrow transplant registry. Int J Hematol 2002;76:393-397.
2. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555-562.
3. Peggs KS, Thomson K, Hart DP et al. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood 2004;103:1548-1556.
4. Applebaum FR. Hematopoietic cell transplantation. In: Kasper DL et al. (eds.). Harrison's Principles of Internal Medicine, 16th ed., vol. 1. New York: McGraw-Hill, 2005:668-673.
5. Bhushan V, Collins RH. Chronic graft-versus-host disease. JAMA 2003;290:2599-2603.
6. Culter C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem cell and bone marrow transplantation: a meta-analysis. J Clin Oncol. 2001;19:3685-3691.
7. Antonini G, Ceschin V, Morino S et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia. Neurology 1998;50:1441-1445.
8. Bleggi-Torres LF, de Medeiros BC, Werner B et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 2000;25:301-307.
9. Gordon B, Lyden E, Lynch J et al. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients. Bone Marrow Transplant 2000;25:79-83.
10. Rosenfeld MS, Pruitt A. Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer. Semin Oncol 2006;33:352-361.
11. Mohrmann RL, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation. Hum Pathol 1990;21:630-639.
12. Jackson SR, Tweeddale MG, Barnett MJ et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998;21:697-704.
13. Woodard P, Helton K, McDaniel H et al. Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis. BMT 2004;33:1151-1157.
14. Baker WJ, Royer GL, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol 1991;9:679-693
15. Sullivan KM, Storb R, Shulman HM et al. Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation. Ann Intern Med 1982;97:182-189.
16. Schuh A, Dandridge J, Haydon P et al. Encephalopathy complicating high-dose melphalan. Bone Marrow Transplant 1999;24: 1141-1143.
17. Tahsildar HI, REmler BF, Creger RJ et al. Delayed, transient encephalopathy after marrow transplantation: case reports and MRI fidings in four patients. J Neurooncol 1996;247:241-250.
18. Meanwell CA, Blake AE, Kelly KA et al. Prediction of ifosfamide/mesna associated encephalopathy. Eur J Cancer Clin Oncol 1986;22:815-819.
19. Anderson NR, Tandon DS. Ifosfamide extrapyramidal neurotoxicity. Cancer 1991;68:72-75.
20. Curtin JP, Koonings PP, Gutierrez M et al. Ifosfamide-induced neurotoxicity. Gynecol Oncol 1991;42:193-196.
21. Cheson BD, Vena DA, Foss FM et al. Neurotoxicity of purine analogues: a review. J Clin Oncol 1994;112:2216-2228.
22. Atkinson K, Clink H, LaMer S et al. Encephalopathy following bone marrow transplantation. Eur J Cancer 1977;13:623-625.
23. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984;101:92-104.
24. Eng RHK, Munsif AN, Yangco BG et al. Seizure propensity with imipenem. Arch Intern Med 1989;149:1881-1883.
25. Frytak S, Moertel CG, Childs DS. Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med 1978;88: 361-362.
26. Wade JC, Meyers JD. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. Ann Intern Med 1983;98:921-925
27. Swan SK, Bennett WM. Oral acyclovir and neurotoxicity. Ann Intern Med 1989;111:188.
28. Cohen SMZ, Minkove JA, Zebley JW III et al. Severe but reversible neurotoxicity from acyclovir. Ann Intern Med 1984; 100:920.
29. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:255-267.
30. Rabinowe SN, Soiffer RJ, Tarell NJ et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991;77:1837-1844.
31. Guinan EC, Tarbell NJ, Niemeyer CM et al. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988; 72:451-455.
32. Haire WD. Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation. Crit Care Med 2002;30[Suppl]:S257-S262.
33. Shah AK. Cyclosporine A neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol 1999;22:67-73.
34. Wong R, Beguelin GZ, de Lima M et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003;122:128-134.
35. Steg RE, Kessinger A, Wszolek ZK. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 1999;23:959-962.
36. Memon M, deMagalhaes-Silverman M, Bloom EJ et al. Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1995;15:283-286.
37. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
38. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Internal Med J 2005;35:83-90.
39. Hurwitz RL, Mahoney DH, Armstrong DL et al. Reversible encephalopathy and seizure as a result of conventional vincristine administration. Med Pediatr Oncol 1988;16:216-219.
40. Higman MA, Port JD, Beauchamp NJ et al. Reversible leukoencephalpathy associated with re-infusion of DMSO preserved stem cells. BMT 2000:26;797-800.
41. Majolino I, Caponetto A, Scime R et al. Wernicke-like encephalopathy after autologous bone marrow transplantation. Haematologica 1990;75:282-284.
42. Bleggi-Torres LF, de Medeiros BC, Ogasawara VSA et al. Iatrogenic Wernicke's encephalopathy in allogeneic bone marrow transplantation: a study of eight cases. Bone Marrow Transplant 1997;20:391-395.
43. Baek JH, Sohn SK, Dim DH et al. Wernicke's encephalopathy after allogeneic stem cell transplantation. Bone Marrow Transplant 2005;35:829-830.
44. Boque C, Petit J, Aguilera C et al. Central and extrapontine myelinolysis following allogeneic peripheral haematopoietic progenitor cell transplantation. Bone Marrow Transplant 2003;31:61-64.
45. Fraser C, Charnas L, Orchard P. Central pontine myelinolysis following bone marrow transplantation complicated by severe hepatic veno-occlusive disease. Bone Marrow Transplant 2005;36:733-734.
46. Mitchell RB, Wagner JE, Karp JE et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. AmerJMed 1988;85:662-667.
47. Sharp RA, Lang CC. Hyperammonaemic encephalopathy in chronic myelomonocytic leukemia. Lancet 1987;1:805.
48. Tse N, Cederbaum S, Glaspy JA. Hyperammonemia following allogeneic bone marrow transplantation. Amer J Hematology 1991;38:140-141.
49. Leonard JV, Kay JDS. Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukemia with asparaginase. Lancet 1986; i:162-163 (letter).
50. Davies SM, Szabo E, Wagner JE et al. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. Bone Marrow Transplant 1996;17:1119-1125.
51. Berry GT, Bridges ND, Nathanson KL et al. Successful use of alternate waste nitrogen agents and hemodialysis in a patient with hyperammonemic coma after heart-lung transplantation. Arch Neurol 1999;56:481-484.
52. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 1994;44:681-684.
53. Walters MC, Patience M, Leisenring W et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996;335:369-376.
54. De la Camara R, Tomas JF, Figuera A et al. High-dose busulfan and seizures. Bone Marrow Transplant 1991;7:363-364.
55. Openshaw H, Slatkin NE. Differential diagnosis of neurological complications in bone marrow transplantation. The Neurologist 1995;1:191-206.
56. Ebner F, Ranner G, Slave I et al. MR findings in methotrexate-induced CNS abnormalities. AJNR 1989;10:959-964.
57. Zakrzewski JL. Cyclosporin A-associated status epilepticus related to hematopoeitic stem cell transplantation for thalassemia. Pediatr Hematol Oncol 2003;20:481-186.
58. Wszolek ZK, Steg RE, Armitage JO. Complex partial status epilepticus after bone marrow transplantation for non-Hodgkin' s lymphoma. Bone Marrow Transplant 1997;19:637-638.
59. Penn I. De novo malignant lesions of the central nervous system. In: Wijdicks EFM (ed.). Blue Books of Practical Neurology: Neurologic Complications in Organ Transplant Recipients, Volume 21. Boston: Butterworth-Heinemann, 1999: 217-227.
60. Kolb HJ, Bender-Gotze CH. Late complications after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990;6:61-72.
61. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784-789.
62. Socie G, Curtis RE, Deeg HJ et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000;18:348-357.
63. Kulkarni S, Powles R, Treleaven J et al. Chronic graft-versus-host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 2000;95:3683-3686.
64. Coplin WM, Cochran MS, Levine SR et al. Stroke after bone marrow transplantation: frequency, aetiology, and outcome. Brain 2001;124:1043-1051.
65. Bleggi-Torres, LF, Werner B, Gasparetto EL. Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients. Bone Marrow Transplant 2002;29:29-32.
66. Colosimo M, McCarthy N, Jayasinghe R et al. Diagnosis and management of subdural haematoma complicating bone marrow transplantation. Bone Marrow Transplant 2000;25:549-552.
67. Kannan K, Koh LP, Linn YC. Subdural hematoma in two hematopoietic stem cell transplant patients with post-dural puncture headache and initially normal CT brain scan. Ann Hematol 2002;81:540-542.
68. Harvey CJ, Peniket AJ, Miszkiel K et al. MR angiographic diagnosis of cerebral venous signs thrombosis following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:791-795.
69. Bertz H, Laubenberger J, Steinfurth G et al. Sinus venous thrombosis: an unusual cause for neurologic symptoms after bone marrow transplantation under immunosuppression. Transplantation 1998;66:241-244.
70. Mori A, Tanaka J, Kobayashi S et al. Fatal cerebral hemorrhage associated with cyclosporin-A/FK506-related encephalopathy after allogeneic bone marrow transplantation. Ann Hematol 2000;79:588-592.
71. Gordon B, Haire W, Kessinger A et al. High frequency of antithrombin-3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991;8:497-502.
72. Gordon BG, Saving Kl, McCallister JA et al. Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;8:323-325.
73. Kaufman PA, Jones RB, Greenberg CS et al. Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Cancer 1990;66:515-521.
74. Qasim W, Gerritsen B, Veys P. Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant 1998;21: 845-847.
75. Richard S, Seigneur M, Blann A et al. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1996;18:955-959.
76. Kalhs P, Brugger S, Schwarzinger I et al. Microangiopathy following allogeneic marrow transplantation. Transplantation 1995;60: 949-957.
77. Windrum P, Morris TCM. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003;31:315.
78. Darabi K, Brown JR, Kao GS. Paradoxical embolism after peripheral blood stem cell infusion. Bone Marrow Transplant 2005;36: 561-562.
79. Jerman MR, Fick RB, Jr. Nonbacterial thrombotic endocarditis associated with bone marrow transplanation. Chest 1986;90:919-922.
80. Patchell RA, White CL, 3rd, Clark AW et al. Nonbacterial thrombotic endocarditis in bone marrow transplant patients. Cancer 1985;55:631-635.
81. Tschuchnigg M, Bradstock KF, Koutts J et al. A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990;5:61-63.
82. Ho VT, Cutler C, Carter S et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:571-575.
83. Padovan CS, Bise K, Hahn J et al. Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke 1999;30:1651-1656.
84. Ma M, Barnes G, Pulliam J et al. CNS angiitis in graft vs. host disease. Neurology 2002;59:1994-1997.
85. Campbell JN, Morris PP. Cerebral vasculitis in graft-versus-host disease. Am J Neuroradiol 2005;26:654-656.
86. De Medeiros BC, de Medeiros CR, Werner B et al. Central nervous system infections following bone marrow transplantation: an autopsy report of 27 cases. J Hematother Stem Cell Res 2000;9:535-540.
87. Van Burik JA, Hackman RC, Nadeem SQ et al. Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis 1997;24:1154-1160.
88. Choucino C, Goodman SA, Greer JP et al. Nocardial infections in bone marrow transplant recipients. Clin Infect Dis 1996;23: 1012-1019.
89. Machado CM, Macedo MC, Castelli JB et al. Clinical features and successful recovery from disseminated nocardiosis after BMT. Bone Marrow Transplant. 1997;17:81-82.
90. Elliott MA, Tefferi A, Marshall WF et al. Disseminated nocardiosis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20:425-426.
91. Carradice D, Szer J. Cerebral nocardiosis after allogeneic bone marrow transplantation. Intern Med J. 2004;34:698-699.
92. Laurence AD, Peggs KS. Cerebral and pulmonary nocardia in a bone marrow transplant patient. Br J Haematol. 2005;129:711.
93. Campos A, Vaz CP, Campilho F et al. Central nervous system tuberculosis following allogeneic stem cell transplantation. Bone Marrow Transplant. 2000;25:567-569.
94. Graus F, Saiz A, Sierra J et al. Neurologic complications of autologous and allogeneic bone marrow transplantation inpatients with leukemia. Neurology 1996;46:1004-1009.
95. Martino R, Martinez C, Brunet S et al. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant. 1996;18:809-812.
96. Aljurf M, Gyger M, Alrajhi A et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant. 1999;24:551-554.
97. Rodriguez M, Chou S, Fisher DC et al. Lyme meningoradiculitis and myositis after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005;41:112-114.
98. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985;18:574-582.
99. Miaux Y, Ribaud P, Williams M et al. MR of cerebral aspergillosis in patients who have had bone marrow transplantation. Am J Neuroradiol 1995;16:555-562.
100. Guermazi A, Gluckman E, Tabti B et al. Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview. Eur Radiol 2003;13:377-388.
101. Khoury H, Adkins D, Miller G et al. Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone Marrow Transplant 1997;20:179-180.
102. Baslar Z, Soysal T, Hanci M et al. Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transplant 1998;22:404-405.
103. LaRocco MT, Burgert SJ. Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 1997;10:277-297.
104. Hagensee ME, Bauwens JE, Kjos B et al. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19:402-108.
105. Maschke M, Dietrich U, Prumbaum M et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999;23:1167-1176.
106. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 2000;49:23, 26, 107.
107. Tolkoff-Rubin NE, Hoving GK, Rubin RH. Central nervous system infections. Chapter 10 in: Wijdicks EFM (ed.). Neurologic Complications in Organ Transplant Recipients. Butterworth-Heinemann, 1999.
108. Nenoff P, Kellermann S, Schober R et al. Rhinocerebral zygomycosis following bone marrow transplantation in chronic myelogenous leukaemia: report of a case and review of the literature. Mycoses 1998;41:365-372.
109. Baddley JW, Moser SA, Sutton DA et al. Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient. J Clin Microbiol 2000;38:395-397.
110. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant 1997;19:685-689.
111. Brinkman K, Debast S, Sauerwein R et al. Toxoplasma retinitis/ encephalitis 9 months after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;21:635-636.
112. Derouin F, Devergie A, Auber P et al. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis 1992;15:267-270.
113. Bretagne S, Costa JM, Kuentz M et al. Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Tranplant 1995;15:809-811.
114. Tefferi A, O'Neill BP, Inwards DJ. Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;21:1285-1286.
115. Dietrich U, Maschke M, Dorfler A et al. MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology 2000;42:14-18.
116. Khoury H, Adkins D, Brown R et al. Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection. Bone Marrow Transplant 1999;23:409-411.
117. Lowenberg B, van Gijn J, Prins E et al. Fatal cerebral toxoplasmosis in a bone marrow transplant recipient with leukemia. Transplantation 1983;35:30-34.
118. Slavin MA, Meyers JD, Remington JS et al. Toxoplasma gondii infection in marrow transplant recipients: a 20-year experience. Bone Marrow Transplant 1994;13:549-557.
119. Roemer E, Blau IW, Basra N et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis 2001;32:1-8.
120. Seong DC, Przepiorka D, Bruner JM et al. Leptomeningeal toxoplasmosis after allogeneic marrow transplantation. Am J Clin Oncol 1993;16:105-108.
121. Bleggi-Torres LF, de Medeiros BC, Werner B et al. Unusual presentation of cerebral toxoplasmosis after BMT. Bone Marrow Transplant 1999;23:855-856.
122. Martino R, Maertens J, Bretagne S et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000;31: 1158-1194.
123. Anderlini P, Przepiorka D, Luna M et al. Acanthamoeba meningoencephalitis after bone marrow transplantation. Bone Marrow Transplant 1994; 14:459-461.
124. Feingold JM, Abraham J, Bilgrami S et al. Acanthamoeba meningoencephalitis following autologous peripheral stem cell transplantation. Bone Marrow Transplant 1998;22:297-300.
125. Atkinson K, Meyers JD, Storb R et al. Varicella zoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation. 1980;29(1):47-50.
126. Kimberlin DW, Whitley RJ. Human herpesvirus-6: neurologic implications of a newly described viral pathogen. J Neurovirol 1998;4:474-185.
127. Bosi A, Zazzi M, Amantini A et al. Fatal herpesvirus-6 encephalitis after unrelated bone marrow transplant. Bone Marrow Transplant 1998;22:285-288.
128. Singh N. Paterson D. Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000;69:2474-2479.
129. Wainwright MS, Martin PL, Morse RP et al. Human herpesvirus-6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001;50:612-619.
130. Gorniak RJT, Young GS, Wiese DE et al. MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem cell transplantation. Am J Neuroradiol 2006;27:87-891.
131. Wang FZ, Linde A, Hagglund H et al. Human herpesvirus-6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999;28:562-568.
132. Yoshihara S, Kato R, Inoue T et al. Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. Transplantation 2004;77:835-838.
133. Demeter LM. JC, BK, and other polyomavirus; progressive multifocal leukoencephalopathy. In: Mandell GL, Bennett JE, Dolin R (eds.). Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone: London, 2000:1645-1651.
134. Re D, Bamborschke S, Feiden W et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999;23:295-298.
135. Przepiorka D, Jaeckle KA, Birdwell RR et al. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 1997;20:983-987.
136. Openshaw H, Slatkin NE, Parker PM et al. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant 1995;15:633-636.
137. Chao MWT, Wirth A, Ryan G et al. Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin's lymphoma. Int J Radiation Oncol Biol Phys 1998;5:1057-1061.
138. Schwartz DL, Schechter GP, Seltzer S et al. Radiation myelitis following allogeneic stem cell transplantation and consolidation radiotherapy for non-Hodgkin's lymphoma. Bone Marrow Transplant 2000;26:1355-1359.
139. Richard S, Fruchtman S, Scigliano E et al. An immunological syndrome featuring transverse myelitis, Evans syndrome, and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia. Bone Marrow Transplant 2000;26: 1225-1228.
140. Bolton CF, Young GB. Critical illness polyneuropathy: current treatment options in neurology 2000;2:489-498.
141. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve 2000;999:S49-S52.
142. Roskrow MA, Kelsey SM, McCarthy M et al. Selective autonomic neuropathy as a novel complication of BMT. Bone Marrow Transplant 1992;10:469-470.
143. Greenspan A, Deeg HG, Cottier-Fox M et al. Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 1990;5:349-352.
144. Amato AA, Barohn RJ, Sahenk Z et al. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993;43:1513-1518.
145. Griggs JJ, Commichau CS, Rapoport AP et al. Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphoma. Am J Hematol 1997;54:332-334.
146. Wen PY, Aleya EP, Simon D et al. Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 1997;49:1711-1714.
147. Parker P, Chao NJ, Ben-Ezra J et al. Polymyositis is a manifestation of chronic graft-versus-host disease. Medicine 1996;75:279-285.
148. Tse S, Saunders EF, Silverman E et al. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host disease. Bone Marrow Transplant 1999;23:397-399.
149. Leano AM, Miller K, White AC. Chronic graft-versus-host disease related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant. Bone Marrow Transplant 2000;26:1117-1120.
150. Couriel DR, Geguelin GZ, Giralt S et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 2002;30:543-546.
151. Stevens AM, Sullivan KM, Nelson JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology 2003;42: 34-39.
152. Lin PC, Hsiao LT, Chen PM. Acute polymyositis after donor lymphocyte infusion. Eur J Haematol 2005;74:166-168.
153. Bolger GB, Sullivan KM, Spence AM et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986;36:1087-1091.
154. Baron F, Sadzot B, Wang F et al. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;22:197-200.
155. Mackey JR, Desai S, Larratt L et al. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997;19:939-942.
156. Dowell JE, Moots PL, Stein RS. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma. Bone Marrow Transplant 1999;24:1359-1361.
157. Zaja F, Russo D, Fuga G et al. Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology 2000;55: 1062-1063.
158. Maury S, Mary JY, Rabian C et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001;115:630-641.
159. Rouah E, Gruber R, Shearer W et al. Graft-versus-host disease in the central nervous system: a real entity? Am J Clin Pathol 1988;89:543-546.
160. Azuno Y, Yaga K, Kaneko T et al. Chronic graft-versus-host disease and seizure. Blood 1998;91:2626-2628.
161. Kamble RT, Chang C-C, Sanchez S et al. Central nervous system graft-versus-host disease: report of two cases and review of the literature. Bone Marrow Transplant 2007;39:49-52.